{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:50:58Z","timestamp":1789573858228,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Repetitive transcranial magnetic stimulation (rTMS) is a widely used treatment for major depressive disorder (MDD), and its effectiveness in preventing relapse\/recurrence of MDD has been explored. Although few small sample controlled studies exist, the protocols of maintenance rTMS therapy were heterogeneous and evidence of its effectiveness is not sufficient. Thus, this study aims to evaluate whether maintenance rTMS is effective in maintaining the treatment response in patients with MDD with a large sample size and feasible study design.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this multicenter open-labelled parallel-group trial we plan to recruit 300 patients with MDD who have responded or remitted to acute rTMS therapy. Participants would be classified into two groups according to their preference; the maintenance rTMS and pharmacotherapy group, and the pharmacotherapy only group. The protocol of maintenance rTMS therapy is once a week for the first six months and once biweekly for the second six months. The primary outcome is the relapse\/recurrence rates during 12\u00a0months following enrollment. Other measures of depressive symptoms and recurrence\/relapse rates at different time points are the secondary outcomes. The primary analysis is the between-group comparison adjusted for background factors using a logistic regression model. We will perform the group comparison with inverse probability of treatment weighting as the sensitivity analysis to ensure the comparability of the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>We hypothesize that maintenance rTMS therapy could be an effective and safe treatment for preventing depressive relapse\/recurrence. Considering the limitation of potential bias owing to the study design, we plan to use statistical approaches and external data to avoid overestimation of the efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Japan Registry of Clinical Trials, ID: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/jrct.niph.go.jp\/en-latest-detail\/jRCT1032220048\">jRCT1032220048<\/jats:ext-link>. Registered 1 May 2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-023-04944-0","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:01:46Z","timestamp":1686880906000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Maintenance repetitive transcranial magnetic stimulation (rTMS) therapy for treatment-resistant depression: a study protocol of a multisite, prospective, non-randomized longitudinal study"],"prefix":"10.1186","volume":"23","author":[{"given":"Ryuichi","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Oi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Kito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"4944_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1017\/S0033291712002395","volume":"43","author":"F Hardeveld","year":"2013","unstructured":"Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Recurrence of major depressive disorder and its predictors in the general population: Results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychol Med. 2013;43:39\u201348.","journal-title":"Psychol Med"},{"key":"4944_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S2215-0366(17)30038-X","volume":"4","author":"R Gueorguieva","year":"2017","unstructured":"Gueorguieva R, Chekroud AM, Krystal JH. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: An individual patient-level data meta-analysis. Lancet Psychiatry. 2017;4:230\u20137.","journal-title":"Lancet Psychiatry"},{"key":"4944_CR3","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1056\/NEJMoa2106356","volume":"385","author":"G Lewis","year":"2021","unstructured":"Lewis G, Marston L, Duffy L, Freemantle N, Gilbody S, Hunter R, et al. Maintenance or discontinuation of antidepressants in primary care. N Engl J Med. 2021;385:1257\u201367.","journal-title":"N Engl J Med"},{"issue":"Suppl 15","key":"4944_CR4","first-page":"13","volume":"64","author":"AA Nierenberg","year":"2003","unstructured":"Nierenberg AA, Petersen TJ, Alpert JE. Prevention of relapse and recurrence in depression: The role of long-term pharmacotherapy and psychotherapy. J Clin Psychiatry. 2003;64(Suppl 15):13\u20137.","journal-title":"J Clin Psychiatry"},{"key":"4944_CR5","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1176\/ajp.151.9.1295","volume":"151","author":"GA Fava","year":"1994","unstructured":"Fava GA, Grandi S, Zielezny M, Canestrari R, Morphy MA. Cognitive behavioral treatment of residual symptoms in primary major depressive disorder. Am J Psychiatry. 1994;151:1295\u20139.","journal-title":"Am J Psychiatry"},{"key":"4944_CR6","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1176\/appi.ajp.2016.16010118","volume":"173","author":"CH Kellner","year":"2016","unstructured":"Kellner CH, Husain MM, Knapp RG, McCall WV, Petrides G, Rudorfer MV, et al. A novel strategy for continuation ECT in geriatric depression: Phase 2 of the PRIDE study. Am J Psychiatry. 2016;173:1110\u20138.","journal-title":"Am J Psychiatry"},{"key":"4944_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/archpsyc.63.12.1337","volume":"63","author":"CH Kellner","year":"2006","unstructured":"Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337\u201344.","journal-title":"Arch Gen Psychiatry"},{"key":"4944_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1176\/appi.ajp.2013.12060734","volume":"170","author":"U Stangier","year":"2013","unstructured":"Stangier U, Hilling C, Heidenreich T, Risch AK, Barocka A, Schl\u00f6sser R, et al. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: A multicenter prospective randomized controlled trial. Am J Psychiatry. 2013;170:624\u201332.","journal-title":"Am J Psychiatry"},{"key":"4944_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/0004867417743343","volume":"52","author":"A Elias","year":"2018","unstructured":"Elias A, Phutane VH, Clarke S, Prudic J. Electroconvulsive therapy in the continuation and maintenance treatment of depression: Systematic review and meta-analyses. Aust N Z J Psychiatry. 2018;52:415\u201324.","journal-title":"Aust N Z J Psychiatry"},{"key":"4944_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jamapsychiatry.2020.3650","volume":"78","author":"J Guidi","year":"2021","unstructured":"Guidi J, Fava GA. Sequential combination of pharmacotherapy and psychotherapy in major depressive disorder: A systematic review and meta-analysis. JAMA Psychiat. 2021;78:261\u20139.","journal-title":"JAMA Psychiat"},{"key":"4944_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12888-018-1610-5","volume":"18","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zhang L, Zhang G, Jin J, Zheng Z. The effect of CBT and its modifications for relapse prevention in major depressive disorder: A systematic review and meta-analysis. BMC Psychiatry. 2018;18:50.","journal-title":"BMC Psychiatry"},{"key":"4944_CR12","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.clinph.2019.11.002","volume":"131","author":"JP Lefaucheur","year":"2020","unstructured":"Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014\u20132018). Clin Neurophysiol. 2020;131:474\u2013528. https:\/\/doi.org\/10.1016\/j.clinph.2019.11.002.","journal-title":"Clin Neurophysiol"},{"key":"4944_CR13","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/j.clinph.2014.05.021","volume":"125","author":"JP Lefaucheur","year":"2014","unstructured":"Lefaucheur JP, Andr\u00e9-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;125:2150\u2013206.","journal-title":"Clin Neurophysiol"},{"key":"4944_CR14","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/archgenpsychiatry.2010.46","volume":"67","author":"MS George","year":"2010","unstructured":"George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67:507\u201316.","journal-title":"Arch Gen Psychiatry"},{"key":"4944_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2021.03.019","volume":"287","author":"H Li","year":"2021","unstructured":"Li H, Cui L, Li J, Liu Y, Chen Y. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: A network meta-analysis of randomized controlled trials. J Affect Disord. 2021;287:115\u201324.","journal-title":"J Affect Disord"},{"key":"4944_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1079","volume":"364","author":"J Mutz","year":"2019","unstructured":"Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: Systematic review and network meta-analysis. BMJ. 2019;364: l1079.","journal-title":"BMJ"},{"key":"4944_CR17","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","volume":"62","author":"JP O\u2019Reardon","year":"2007","unstructured":"O\u2019Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: A multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208\u201316.","journal-title":"Biol Psychiatry"},{"key":"4944_CR18","doi-asserted-by":"crossref","unstructured":"Benadhira R, Thomas F, Bouaziz N, Braha S, Andrianisaina PS-K, Isaac C, et al. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD). Psychiatry Res. 2017;258:226\u201333.","DOI":"10.1016\/j.psychres.2017.08.029"},{"key":"4944_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ajp.162.1.193","volume":"162","author":"R Benadhira","year":"2005","unstructured":"Benadhira R, Saba G, Samaan A, Dumortier G, Lipski H, Gastal D, et al. Transcranial magnetic stimulation for refractory depression. Am J Psychiatry. 2005;162:193.","journal-title":"Am J Psychiatry."},{"key":"4944_CR20","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.4088\/JCP.11m07413","volume":"73","author":"KR Connolly","year":"2012","unstructured":"Connolly KR, Helmer A, Cristancho MA, Cristancho P, O\u2019Reardon JP. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: Results observed with the first 100 consecutive cases of depression at an Academic Medical Center. J Clin Psychiatry. 2012;73:e567\u201373.","journal-title":"J Clin Psychiatry"},{"key":"4944_CR21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.4088\/JCP.13m08977","volume":"75","author":"DL Dunner","year":"2014","unstructured":"Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: Durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014;75:1394\u2013401.","journal-title":"J Clin Psychiatry"},{"key":"4944_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.brs.2012.05.003","volume":"6","author":"PB Fitzgerald","year":"2013","unstructured":"Fitzgerald PB, Grace N, Hoy KE, Bailey M, Daskalakis ZJ. An open label trial of clustered maintenance rTMS for patients with refractory depression. Brain Stimul. 2013;6:292\u20137.","journal-title":"Brain Stimul"},{"key":"4944_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/15622975.2016.1255353","volume":"19","author":"F Haesebaert","year":"2018","unstructured":"Haesebaert F, Moirand R, Schott-Pethelaz AM, Brunelin J, Poulet E. Usefulness of repetitive transcranial magnetic stimulation as a maintenance treatment in patients with major depression. World J Biol Psychiatry. 2018;19:74\u20138.","journal-title":"World J Biol Psychiatry"},{"key":"4944_CR24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/15622975.2011.639802","volume":"15","author":"EV Harel","year":"2014","unstructured":"Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study. World J Biol Psychiatry. 2014;15:298\u2013306.","journal-title":"World J Biol Psychiatry"},{"key":"4944_CR25","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.4088\/JCP.v66n1205","volume":"66","author":"JP O\u2019Reardon","year":"2005","unstructured":"O\u2019Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry. 2005;66:1524\u20138.","journal-title":"J Clin Psychiatry"},{"key":"4944_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.brs.2015.11.007","volume":"9","author":"NS Philip","year":"2016","unstructured":"Philip NS, Dunner DL, Dowd SM, Aaronson ST, Brock DG, Carpenter LL, et al. Can medication free, treatment-resistant, depressed patients who initially respond to TMS be maintained off medications? A prospective, 12-month multisite randomized pilot study. Brain Stimul. 2016;9:251\u20137.","journal-title":"Brain Stimul"},{"key":"4944_CR27","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fneur.2015.00016","volume":"6","author":"C Rapinesi","year":"2015","unstructured":"Rapinesi C, Bersani FS, Kotzalidis GD, Imperatori C, Del Casale A, Di Pietro S, et al. Maintenance Deep Transcranial Magnetic Stimulation Sessions are Associated with Reduced Depressive Relapses in Patients with Unipolar or Bipolar Depression. Front Neurol. 2015;6:16.","journal-title":"Front Neurol"},{"key":"4944_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jad.2013.05.062","volume":"151","author":"R Richieri","year":"2013","unstructured":"Richieri R, Guedj E, Michel P, Loundou A, Auquier P, Lan\u00e7on C, et al. Maintenance transcranial magnetic stimulation reduces depression relapse: A propensity-adjusted analysis. J Affect Disord. 2013;151:129\u201335.","journal-title":"J Affect Disord"},{"key":"4944_CR29","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brs.2018.10.001","volume":"12","author":"S Senova","year":"2019","unstructured":"Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis. Brain Stimul. 2019;12:119\u201328.","journal-title":"Brain Stimul"},{"key":"4944_CR30","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1038\/s41398-017-0001-x","volume":"7","author":"HN Wang","year":"2017","unstructured":"Wang HN, Wang XX, Zhang RG, Wang Y, Cai M, Zhang YH, et al. Clustered repetitive transcranial magnetic stimulation for the prevention of depressive relapse\/recurrence: A randomized controlled trial. Transl Psychiatry. 2017;7:1292.","journal-title":"Transl Psychiatry"},{"key":"4944_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2021.102970","volume":"68","author":"Y Matsuda","year":"2022","unstructured":"Matsuda Y, Yamazaki R, Shigeta M, Kito S. A 12-month maintenance therapy using repetitive transcranial magnetic stimulation for Treatment-resistant Depression: A report of two cases. Asian J Psychiatr. 2022;68: 102970.","journal-title":"Asian J Psychiatr"},{"key":"4944_CR32","unstructured":"The Japanese Society of Psychiatry and Neurology. The Japanese guidelines for the appropriate use of repettitive transcranial magnetic stimulation (Japanese). https:\/\/www.jspn.or.jp\/uploads\/uploads\/files\/activity\/Guidelines_for_appropriate_use_of_rTMS.pdf. Accessed 14 May 2023."},{"key":"4944_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jad.2020.06.067","volume":"276","author":"PB Fitzgerald","year":"2020","unstructured":"Fitzgerald PB. An update on the clinical use of repetitive transcranial magnetic stimulation in the treatment of depression. J Affect Disord. 2020;276:90\u2013103.","journal-title":"J Affect Disord"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-023-04944-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-023-04944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:03:34Z","timestamp":1686881014000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-023-04944-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4944"],"URL":"https:\/\/doi.org\/10.1186\/s12888-023-04944-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,16]]},"assertion":[{"value":"9 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study has been approved by the National Center of Neurology and Psychiatry Clinical Research Review Board (approval number: CR21-004). All the participants will provide written informed consent and will be informed of their right to withdraw from the study before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Ryuichi Yamazaki reports personal fees from Inter-Riha CO., Ltd., outside the submitted work; Shinsuke Kito reports grants and personal fees from Inter Reha CO., Ltd., Kyowa Pharmaceutical Industry CO., Ltd., Sumitomo Pharma CO., Ltd., Otsuka Pharmaceutical CO., Ltd., Teijin Pharma Limited, and Viatris Inc., outside the submitted work; Mari Oba received personal fees from Astrazeneca K.K., EP-SOGO Co., Ltd., and Pfizer Inc., outside the submitted work; Hideki Oi received research funding from Otsuka Pharmaceutical CO., Ltd., Sumitomo Pharma Co., Ltd.; the other authors have no competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"437"}}